Want to see TSE:IFOS full AI Analyst Report?
Top Page
Itafos
(IFOS)
Select Model
Select Model
Rating:59Neutral
Price Target:
C$2.00
▼(-18.03% Downside)
Action:Reiterated
Date:08/10/26
The score is primarily driven by solid financial resilience from a low-leverage balance sheet and ongoing profitability, offset by weakened cash generation (negative TTM free cash flow and low cash conversion). Technicals are a notable drag with a clear downtrend and weak momentum, while the low P/E provides some valuation support.
Positive Factors
Conservative balance sheet
Low leverage gives Itafos meaningful financial flexibility as it operates through changing fertilizer conditions. The improved capital structure reduces balance-sheet strain, supports investment in phosphate assets, and provides greater capacity to manage volatility than the materially more leveraged position reported in 2021.
Negative Factors
Negative free cash flow
Negative free cash flow weakens the quality of current earnings and may require Itafos to rely more heavily on its balance sheet or external funding. If the shortfall persists, it could constrain capital investment, reduce financial flexibility, and delay improvement in shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage gives Itafos meaningful financial flexibility as it operates through changing fertilizer conditions. The improved capital structure reduces balance-sheet strain, supports investment in phosphate assets, and provides greater capacity to manage volatility than the materially more leveraged position reported in 2021.
Read all positive factors
Itafos (IFOS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$403.20M
Dividend Yield6.53%
Average Volume (3M)39.92K
Price to Earnings (P/E)5.5
Beta (1Y)0.33
Revenue Growth10.52%
EPS Growth-53.33%
CountryCA
Employees470
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)0.27
Shares Outstanding194,780,270
10 Day Avg. Volume33,519
30 Day Avg. Volume39,920
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.95
Price to Sales (P/S)0.73
P/FCF Ratio87.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.75Price Target Upside53.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.07
Revenue Forecast (FY)C$641.16M
Itafos Business Overview & Revenue Model
Company Description
Itafos, Inc. engages in the provision of phosphate fertilizers and specialty products. It operates through the following segments: Itafos Conda, Itafos Arraias, Development and Exploration, and Corporate. The Itafos Conda segment produces and sell...
How the Company Makes Money
Itafos makes money primarily by producing and selling phosphate-based products. Its revenue model centers on (1) sales of phosphate fertilizer and fertilizer-grade phosphate products to distributors, retailers, and agricultural end markets, where ...
Itafos Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
80
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 575.90M | 567.74M | 491.24M | 465.52M | 593.29M | 413.25M |
| Gross Profit | 85.50M | 138.75M | 148.79M | 118.56M | 214.88M | 136.88M |
| EBITDA | 133.28M | 158.22M | 149.25M | 53.75M | 219.59M | 136.82M |
| Net Income | 56.98M | 118.16M | 87.79M | 3.86M | 115.10M | 51.03M |
Balance Sheet | ||||||
| Total Assets | 825.61M | 861.76M | 695.86M | 587.23M | 614.01M | 633.85M |
| Cash, Cash Equivalents and Short-Term Investments | 53.20M | 70.36M | 74.37M | 31.05M | 42.81M | 31.57M |
| Total Debt | 83.87M | 112.47M | 108.17M | 103.83M | 143.90M | 254.09M |
| Total Liabilities | 391.48M | 427.52M | 348.03M | 328.50M | 360.89M | 499.25M |
| Stockholders Equity | 434.13M | 434.24M | 347.83M | 258.73M | 252.35M | 133.44M |
Cash Flow | ||||||
| Free Cash Flow | -36.79M | 4.69M | 52.57M | 39.96M | 169.37M | 60.42M |
| Operating Cash Flow | 47.40M | 84.19M | 120.05M | 94.72M | 208.37M | 94.50M |
| Investing Cash Flow | -53.12M | -41.29M | -65.20M | -53.33M | -39.00M | -34.08M |
| Financing Cash Flow | -40.23M | -47.71M | -9.37M | -54.23M | -158.32M | -38.43M |
Itafos Technical Analysis
Negative
2.44
Price Trends
2.27
Negative
2.33
Negative
2.78
Negative
Market Momentum
-0.07
Negative
38.50
Neutral
79.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFOS, the sentiment is Negative. The current price of 2.44 is above the 20-day moving average (MA) of 2.08, above the 50-day MA of 2.27, and below the 200-day MA of 2.78, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 38.50 is Neutral, neither overbought nor oversold. The STOCH value of 79.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:IFOS.
Itafos Peers Comparison
UnderperformOutperform
Sector (55)
TSE:IFOS
Itafos
2.07
-1.41
-40.52%
TSE:CHE.UN
Chemtrade Logistics
14.62
1.78
13.84%
TSE:ARGO
Argo Living Soils Corp.
1.06
0.31
41.33%
Itafos Corporate Events
Business Operations and StrategyPrivate Placements and Financing
Itafos Extends and Upsizes Credit Facilities to Boost Liquidity
Positive
Sep 29, 2026
Itafos has amended and extended its key credit facilities, refinancing its existing term loan and letter of credit structure with a new US$140 million term loan and US$30 million letter of credit facility led by RBC Capital Markets, Texas Capital ...
Business Operations and StrategyFinancial Disclosures
Itafos Grows Q2 Revenue but Faces Margin Pressure Amid Global Phosphate Turmoil
Negative
Aug 5, 2026
Itafos reported Q2 2026 revenues of $144.0 million, up 14% year on year, driven by higher prices and fertilizer and sulfuric acid volumes in Brazil, while safety performance improved and fertilizer output at Conda and Arraias remained strong despi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.